RASNA THERAPEUTICS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIESRasna Therapeutics Inc. • April 6th, 2018 • Pharmaceutical preparations • New York
AGREEMENT OF MERGER AND PLAN OF REORGANIZATIONAgreement of Merger and Plan of Reorganization • August 17th, 2016 • Active With Me Inc. • Services-computer processing & data preparation • New York
THIS AGREEMENT OF MERGER AND PLAN OF REORGANIZATION (this “Agreement”) is made and entered into on August 15, 2016 by and among Active With Me, Inc., a Nevada corporation (“Parent”), Rasna Acquisition Corp., a Delaware corporation (“Acquisition Corp.”), which is a wholly-owned subsidiary of Parent, and Rasna Therapeutics, Inc., a Delaware corporation (the “Company”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • August 17th, 2016 • Active With Me Inc. • Services-computer processing & data preparation • New York
THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of August 15, 2016, is made by and between ACTIVE WITH ME, Inc. a Nevada corporation (“Seller”), and each of the individuals listed under the heading “Buyers” on the signature page hereto (collectively, “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 31st, 2017 • Rasna Therapeutics Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August __, 2017, between Rasna Therapeutics, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
12% CONVERTIBLE PROMISSORY NOTE DUE October 19 2019Rasna Therapeutics Inc. • February 14th, 2019 • Pharmaceutical preparations • New York
THIS CONVERTIBLE PROMISSORY NOTE is one of a series of duly authorized and validly issued Notes of Rasna Therapeutics, Inc., a Nevada corporation, (the “Borrower”), having its principal place of business at 420 Lexington Avenue, Suite 2525, New York, New York 10170, due October 19, 2019 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).
12% CONVERTIBLE PROMISSORY NOTE DUE AUGUST 8, 2019Rasna Therapeutics Inc. • August 9th, 2018 • Pharmaceutical preparations • New York
THIS CONVERTIBLE PROMISSORY NOTE is one of a series of duly authorized and validly issued Notes of Rasna Therapeutics, Inc., a Nevada corporation, (the “Borrower”), having its principal place of business at 420 Lexington Avenue, Suite 2525, New York, New York 10170, due August 8, 2019 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • June 30th, 2020 • Rasna Therapeutics Inc. • Pharmaceutical preparations • Delaware
THJS ASSET PURCHASE AGREEMENT (the "Agreement") is made and entered into as of April 16, 2020 ("Effective Date"), by and between: TIZIANA LIFE SCIENCES, PLC, a Delaware corporation ("Purchaser") and RASNA THERAPEUTICS, INC„ a Nevada corporation ("Seller"). Certain capitalized terms used in this Agreement and not defined in the body hereof are defined in Exhibit A
AGREEMENT OF CONVEYANCE, TRANSFER AND ASSIGNMENT OF ASSETS AND ASSUMPTION OF OBLIGATIONSAgreement of Conveyance • August 17th, 2016 • Active With Me Inc. • Services-computer processing & data preparation • New York
This Agreement of Conveyance, Transfer and Assignment of Assets and Assumption of Obligations (“Transfer and Assumption Agreement”) is made as of August 15, 2016, by Active With Me, Inc., a Nevada corporation (“Assignor”), and Active With Me Holdings, Inc., a Delaware corporation and a wholly-owned subsidiary of Assignor (“Assignee”).
AGREEMENT OF MERGER AND PLAN OF REORGANIZATIONAgreement of Merger and Plan of Reorganization • August 17th, 2016 • Active With Me Inc. • Services-computer processing & data preparation • New York
THIS AGREEMENT OF MERGER AND PLAN OF REORGANIZATION (this “Agreement”) is made and entered into on May 17, 2016 by and among Rasna Therapeutics, Inc., a Delaware corporation (“Parent”), Falconridge Holdings Limited, a corporation organized under the laws of the British Virgin Islands (“Falconridge”), which is a wholly-owned subsidiary of Parent, and Arna Therapeutics Limited, a corporation formed under the laws of the British Virgin Islands (the “Company”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • June 30th, 2017 • Rasna Therapeutics Inc. • Pharmaceutical preparations • Pennsylvania
This Executive Employment Agreement (the “Agreement”) is entered into effective May 24, 2017 (the “Effective Date”), by and between Shailubhai Kunwar (the “Executive”) and Rasna Therapeutics, Inc. (the “Company”).
